Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

Multiple Cancer Types

This is an open-label, Phase 2, multicenter study to evaluate the efficacy, safety,
tolerability, and pharmacokinetic profiles of botensilimab as monotherapy and in combination
with balstilimab or standard-of-care treatments in participants with refractory metastatic
colorectal cancer.
Colon, Rectal
Eng, Cathy

To learn more about any of our clinical
trials, call 615-936-8422.